Sarfe Pharms Drug Patent Portfolio
Sarfe Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Sarfe Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10154963 | Controlled-release formulations comprising Torsemide | 06 Oct, 2033 | Active |
Latest Legal Activities on Sarfe Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sarfe Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Surcharge for late Payment, Small Entity | 17 Aug, 2022 | US10154963 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 17 Aug, 2022 | US10154963 |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Aug, 2022 | US10154963 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Sep, 2021 | US10154963 |
|
Correspondence Address Change
Critical
| 15 Sep, 2021 | US10154963 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 18 Dec, 2018 | US10154963 |
|
Recordation of Patent Grant Mailed
Critical
| 18 Dec, 2018 | US10154963 |
|
Email Notification
Critical
| 29 Nov, 2018 | US10154963 |
|
Issue Notification Mailed
Critical
| 28 Nov, 2018 | US10154963 |
|
Application Is Considered Ready for Issue
Critical
| 14 Nov, 2018 | US10154963 |
| Dispatch to FDC | 14 Nov, 2018 | US10154963 |
|
Issue Fee Payment Received
Critical
| 13 Nov, 2018 | US10154963 |
|
Issue Fee Payment Verified
Critical
| 13 Nov, 2018 | US10154963 |
| Supplemental Papers - Oath or Declaration | 12 Nov, 2018 | US10154963 |
| Workflow - Drawings Finished | 29 Oct, 2018 | US10154963 |
Sarfe Pharms's Family Patents
Sarfe Pharms drugs have patent protection in a total of 2 countries. It has a significant patent presence in the US with 88.9% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Sarfe Pharms Drug List
Given below is the complete list of Sarfe Pharms's drugs and the patents protecting them.
1. Soaanz
Soaanz is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10154963 | Controlled-release formulations comprising Torsemide |
06 Oct, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Soaanz's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List